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Figure 1. Pak Dynamics during the Cell Cycle
A Pak/PIX/GIT complex is present at focal adhesions in nonmitotic cells, anchored by Paxillin (green crescents). (1) During mitosis, Pak is
recruited to a centrosomal GIT1/PIX complex, which it binds via a PIX binding element (thick black rectangle). (2) Upon binding GIT1/PIX,
Pak undergoes a conformational change and becomes activated. The p21 binding regulatory domain of Pak (black/gray region) is not involved
in this activation step. Activated Pak dissociates from the complex, and the kinase domain (red box) binds Aurora-A, which Pak activates by
phosphorylation of Thr 288 and Ser 342. (3) Pak is inactivated and exits the centrosomal environment.
though cells still manage to find a way to divide. These
findings suggest that the G2/M functions of Aurora-A
are under the control of another set of regulatory pro-
teins, such as TPX2.
The work of Zhao et al. is important not only because
it provides new insights into the activation of Aurora-A
but also because it supports the idea that there is sig-
nificant crosstalk between focal adhesions and the mi-
totic apparatus. Indeed, the pool of proteins that form
complexes at focal adhesions form the same complexes
at the centrosomes, as evidenced by the behavior of
Pak1/PIX/GIT1 or the presence of HEF1 and Ajuba at
both focal adhesions and centrosomes. It is possible
that disassembly of focal adhesions releases such pro-
tein complexes and leads to the activation of Aurora-A,
thereby linking loss of adhesion to cell cycle pro-
gression, such as that seen in “rounded-up” mitotic
cells. As is often the case when one particular puzzle
is solved, the findings of Zhao et al. bring new ques-
tions into view: What impels Pak to transit to and from
centrosomes during the cell cycle? What is the relation-
ship between Pak, Ajuba, and HEF1? Is this all part of
some grand scheme linking integrin signals to centro-
some maturation? For those answers, stay tuned, as
signaling and cell-cycle laboratories converge on Au-
rora-A .
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How Hypoxia Impacts
Differentiation
In the current issue of Developmental Cell, work by
Gustafsson and coworkers demonstrates that hypoxia
synergizes with Notch to inhibit differentiation of
myogenic and neural precursor cells (Gustafsson et
al., 2005). This effect requires a newly described in-
teraction between the transcriptionally active form of
HIF-1 and the intracellular domain of Notch.
What role does oxygen, and its delivery, play during
embryogenesis? That there is a connection has been
apparent for many years. Studies of mammalian embry-
ogenesis in the 1970s showed that successful develop-
ment of the neural fold is highly sensitive to oxygena-
tion levels; it was demonstrated that when mammalian
embryos were cultured, the degree of culture oxygena-
tion must be kept to very specific levels (Morriss and
New, 1979). Interestingly, these studies also showed
that switching from a hypoxic to normoxic and ulti-
mately a hyperoxic state is essential for the successful
formation and closure of the neural fold in mammalian
embryos, at least ex utero. This embryonic oxygenation
shift has never been well characterized at a molecular
level. However, an interesting intersection occurred in
more recent studies, in which it has been shown that
the HIF-1 transcription factor, which regulates most
hypoxic response, is also required for embryogenesis,
and indeed, when mutated it gives rise to animals that
have defects in neural fold formation and closure (Iyer
et al., 1998; Maltepe et al., 1997; Ryan et al., 1998).
The exposure to low levels of oxygen triggers a HIF-1
response in virtually every vertebrate cell type studied,
including embryonic stem cells (Ryan et al., 1998). HIF-1
belongs to the basic helix-loop-helix (bHLH) and PER-
ARNT-SIM (PAS) family of transcription factors and is
composed of two subunits: HIF-1β (also know as
ARNT), which is constitutively expressed, and HIF-1α,
which is tightly regulated by oxygen tension. At nor-
moxia, HIF-1α protein is hydroxylated at two proline
residues (P402 and P564) by prolyl hydroxylase domain
proteins (PHD), making it recognizable by the protein
von Hippel-Lindau (pVHL) complex. The interaction be-
tween pVHL and HIF-1α drives ubiquitin-mediated deg-
radation by the 26S proteasome. Under physiologically
moderate oxygenation levels, HIF-1α also undergoes a
hydroxylation on Asn 803 by Factor Inhibiting HIF 1
(FIH-1). This modification inhibits HIF-1 transcriptional
activity, as it prevents binding to the coactivator p300/
CBP. When oxygen levels decrease, the mechanisms of
degradation/inactivation of HIF-1α are inhibited, so it
accumulates and translocates into the nucleus, where
it binds to HIF-1β and cofactors and activates tran-
scription.Among the defined developmental roles of hypoxic
response in low oxygen are stimulation of the prolifera-
tion of CNS precursor cells (Studer et al., 2000) and
neural crest stem cells (Morrison et al., 2000), promo-
tion of survival of the chondrocyte growth plate (Schi-
pani et al., 2001), and inhibition of adipocyte differentia-
tion (Yun et al., 2002), but the molecular processes
underlying these effects are divergent and in some
cases not understood at all. In this regard, the work by
the Poellinger and Lendahl groups is groundbreaking,
in that it reports a novel link between hypoxia and
Notch that at least in part explains how these two path-
ways synergize to inhibit differentiation of precursor
cells during early stages of embryogenesis (Gustafsson
et al., 2005).
Notch signaling is a highly evolutionarily conserved
pathway that regulates many aspects of cellular differ-
entiation in multicellular organisms. It mediates cell-cell
signaling between adjacent cells expressing Notch re-
ceptors and Notch ligands. Notch receptors are single-
pass transmembrane proteins with several tandem epi-
dermal growth factor-like and LIN12/Notch repeats in
the extracellular domain, a RAM domain and ankyrin
repeats in the intracellular domain (ICD), as well as
nuclear localization sequences. Notch activation takes
place after binding to ligand. Notch ligands are also
single-pass transmembrane proteins and belong to the
DSL family (Delta-Serrate-Lag2). After binding to li-
gand, the Notch receptor undergoes two proteolytic
cleavages: The first is metalloprotease-dependent and
takes place in the extracellular domain (S2), and the
second is endomembranous and mediated by a γ-secre-
tase complex (S3). This releases the intracellular do-
main of Notch (ICD), which translocates to the nucleus
and associates with the CSL transcription factor and
coactivators such as CBP/p300 and mastermind-like
proteins, and regulates the expression of target genes
such as Hes and Hey.
The Poellinger and Lendahl groups found that hyp-
oxic inhibition of differentiation of myogenic cells, sat-
ellite cells, and neural stem cells was reverted after in-
cubation with the γ-secretase inhibitor L-685,458; in
turn demonstrating that the cleavage of the Notch re-
ceptor was necessary for this inhibition (Gustafsson et
al., 2005). Supporting this, hypoxia stimulated the ex-
pression of Notch downstream genes Hes-1 and Hey-2.
Analysis of the expression of promoter constructs in
the presence of an exogenous form of the Notch ICD
revealed that it synergizes with hypoxia in the activa-
tion of these constructs. Intriguingly, it also synergized
with HIF-1α inductors such as CoCl2, suggesting a role
for HIF-1α in this process.
The next step was to identify potential molecular me-
diators acting between hypoxic and Notch activation
pathways. Pulse-chase experiments demonstrated that
hypoxia increases the half-life of Notch, an effect that
requires the presence of HIF-1α. Immunoprecipitation
experiments showed that there is a physical interaction
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576between HIF-1α and Notch 1 ICD. To further character-
ize this, a series of truncated HIF-1α constructs were
expressed in P19 cells together with a Notch ICD plas-
mid, finding that there are two interaction domains in
HIF-1α, one located in the N-terminal domain of HIF,
spanning residues 1–390, and the second between resi-
dues 390 and 531. Interestingly, cotransfection of HIF-
1α and Notch 1 ICD resulted in increased expression of
the 12XCSL-luc plasmid, both at normoxia and hyp-
oxia, but the truncated forms of HIF-1α failed to do so,
demonstrating that only a transcriptionally active form
of HIF-1α can increase Notch signaling. Finally, the au-
thors demonstrate with chromatin immunoprecipitation
assays that HIF-1α is recruited to the Hes Notch-respon-
sive promoter under activation of both Notch signaling
and low oxygen levels; they also show, using HIF-1α
mutant cell lines, that Notch transcriptional activation
during hypoxia requires HIF-1 function.
These findings suggest a new mode of action of HIF-
1α under hypoxia that differs from the canonical re-
sponse, in which it needs to dimerize with HIF-1β in
order to activate the transcription of hypoxia-respon-
sive genes. Based on these data, the authors propose
a model in which HIF-1α, once stabilized by hypoxia,
interacts with the Notch 1 ICD and is an active part of
the Notch 1 ICD/CSL transcriptional complex. There,
HIF-1α would contribute to stabilize Notch 1 ICD and
would enhance the transcriptional activity of the com-
plex through the recruitment of coactivators such as
CBP/p300. This model has strong similarities with the
mechanism of interactions between Notch and BMP/
TGF-β signaling pathways, in which the intracellular
mediators SMAD1 and SMAD3 interact with Notch 1
ICD, and there is no need of SMAD binding to DNA to
promote a response (Blokzijl et al., 2003; Dahlqvist et
al., 2003). Whether this model of interaction with Notch
is followed by other stimuli promoting stem cell dedif-
ferentiation remains to be elucidated.
Despite the evidence suggesting a major role for HIF-
1α in the interaction between hypoxia and Notch, the
involvement of other hypoxia-related molecules cannot
be ruled out. Whereas Notch regulation seems to be
independent of pVHL, immunoprecipitation experi-
ments showed FIH-1 physically interacts with Notch 1
ICD. Also, FIH-1 expression in P-19 cells decreased
12xCSL-luc activity when coexpressed with HIF-1α, but
also in its absence, suggesting a more direct role of
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CIH-1 in the regulation of Notch signaling; this will cer-
ainly be worthy of study in the future.
It would also be interesting to study the effect of
otch in the hypoxic response. Even though Notch 1
CD was not recruited to the promoter of the hypoxia
esponsive gene PGK-1, the absence of the Notch li-
and Serrate-1 in the culture caused a decrease in the
mount of HIF-1α bound to the promoter, and incuba-
ion with L-685,458 decreased the mRNA expression of
he HIF-1 target PGK-1 at normoxia and hypoxia. The
nteraction between these two essential pathways thus
ppears to be robust, and will likely spawn a great deal
f further effort to understand what was first approached
n embryo cultures more than 30 years ago: the role
layed by oxygen in regulating developmental fate.
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